Drug design, development and therapy

MK-4 may improve diabetic bone loss by boosting cell cleanup in blood vessel cells during new bone growth

Updated

Abstract

MK-4 may alleviate by protecting and promoting bone formation.

  • MK-4 improved type H vessel health and supported bone mass maintenance in a mouse model of diabetic osteoporosis.
  • In vitro experiments indicated that MK-4 could reverse endothelial cell dysfunction caused by high glucose conditions.
  • MK-4 enhanced the ability of osteoblasts to differentiate into bone-forming cells.
  • The beneficial effects of MK-4 on endothelial cells appear to involve PINK1/Parkin-mediated .
  • The ERK signaling pathway is suggested to play a critical role in MK-4's effects on mitophagy.

Simplified

Key numbers

20
Mouse Cohort Size
Total number of male C57 BL/6 mice used in the study
30 mg/kg
MK-4 Dosage
Dosage of MK-4 administered to the + MK-4 group
15 mg/kg
3-MA Dosage
Dosage of 3-Methyladenine given to block MK-4's autophagy-promoting effects

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

The authors declare that they have no conflicts of interest with the contents of this article.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free